Suppr超能文献

1998-2018 年澳大利亚新南威尔士州一家主要儿科医院与呼吸道合胞病毒相关的死亡病例。

Respiratory Syncytial Virus-attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia, 1998-2018.

机构信息

From the Discipline of Child and Adolescent Health, University of Sydney.

National Centre for Immunisation Research and Surveillance.

出版信息

Pediatr Infect Dis J. 2022 Mar 1;41(3):186-191. doi: 10.1097/INF.0000000000003398.

Abstract

BACKGROUND

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection and an important contributor to child mortality. In this study, we estimated the frequency and described the clinical features of RSV-attributable deaths in Australian children.

METHODS

We conducted a retrospective observational study of RSV-associated deaths in hospitalized children <16 years of age over a 21-year period (1998-2018) in a pediatric tertiary/quaternary referral hospital in New South Wales (NSW), Australia. RSV-associated deaths were identified, reviewed, and classified according to RSV contribution to death. For 'RSV-attributable' deaths, we estimated frequency, case fatality ratio (CFR), and population death rate. We described demographic and clinical features of cases.

RESULTS

There were 20 RSV-attributable deaths. RSV was considered the primary cause of death for five cases and a contributory cause for 15 cases. The CFR among hospitalized cases was 0.2% (20/9779). The annual death rate was 0.6 per 10,000 hospitalized children. The population death rate was 1.2 (95% confidence interval 0.5-2.7) per million children <16 years of age in NSW. The median age at death was 28.7 months (interquartile range 8.8-75.0). All children had at least one medical comorbidity. Over half the deaths occurred in children ≥2 years of age (11, 55%). RSV healthcare-associated infection (RSV-HAI) was common (11, 55%).

CONCLUSIONS

RSV-attributable death is infrequent in this setting. Deaths occurred exclusively in children with medical comorbidity and a high proportion were RSV-HAI. Children with medical comorbidity, including those ≥2 years of age, should be prioritized for targeted prevention of RSV disease.

摘要

背景

呼吸道合胞病毒(RSV)是急性下呼吸道感染的主要原因,也是导致儿童死亡的重要因素。在这项研究中,我们估计了澳大利亚儿童中 RSV 相关死亡的频率,并描述了其临床特征。

方法

我们对新南威尔士州(NSW)一家儿科三级/四级转诊医院 21 年来(1998-2018 年)住院的<16 岁儿童中与 RSV 相关的死亡病例进行了回顾性观察研究。根据 RSV 对死亡的贡献,确定、审查并分类与 RSV 相关的死亡。对于“RSV 归因”死亡,我们估计了频率、病死率(CFR)和人群死亡率。我们描述了病例的人口统计学和临床特征。

结果

共有 20 例 RSV 归因死亡。RSV 被认为是 5 例死亡的主要原因,15 例死亡的次要原因。住院病例的 CFR 为 0.2%(20/9779)。每年每 10000 名住院儿童的死亡率为 0.6 例。在 NSW,每 100 万<16 岁儿童的人口死亡率为 1.2(95%置信区间 0.5-2.7)。死亡时的中位年龄为 28.7 个月(四分位距 8.8-75.0)。所有儿童均至少有一种合并症。超过一半的死亡发生在≥2 岁的儿童(11,55%)。RSV 与医疗保健相关的感染(RSV-HAI)很常见(11,55%)。

结论

在这种情况下,RSV 归因死亡很少见。死亡仅发生在有合并症的儿童中,其中很大一部分是 RSV-HAI。患有合并症的儿童,包括≥2 岁的儿童,应优先考虑针对 RSV 疾病的靶向预防。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验